Biomarkers in Cerebrospinal Fluid of Children With Tick-borne Encephalitis: Association With Long-term Outcome

Background: Tick-borne encephalitis (TBE) is a major cause of meningoencephalitis in children in endemic areas, and long-term residual problems are not uncommon. Currently, no predictive markers in the acute phase are available that identify children at risk of incomplete recovery. We measured cytokines, chemokines and markers of neuronal damage in cerebrospinal fluid (CSF) in children with TBE and central nervous system (CNS) involvement. Methods: CSF from 37 children with TBE with CNS involvement was analyzed. Concentrations of 16 cytokines, chemokines and 5 markers of neuronal damage were assessed in CSF, using a multiplex assay, and correlated with clinical findings in the acute phase (n = 37), and with long-term outcome (n=22). Results: Significantly higher levels of CSF interferon (IFN)-&ggr;, interleukin (IL)-4, IL-6 and IL-8 were detected in the acute phase from children who later developed sequelae. Although most of the studied markers of neuronal damage displayed no significant differences between children with sequelae and those with good outcome, neuron-specific enolase correlated inversely. The grade of CSF pleocytosis correlated positively with the levels of IFN-&ggr;, IL-4 and IL-6; however, pleocytosis alone did not predict sequelae. Increasing age correlated positively with IL-4, IL-6 and IL-8 values. Conclusions: The mechanism underlying the CNS pathology causing sequelae in TBE appears related to the grade of inflammation in CNS, rather than to direct neuronal destruction. High concentration of IFN-&ggr;, IL-4, IL-6 and IL-8 in CSF might indicate a risk for incomplete recovery in childhood TBE.

[1]  L. Forsman,et al.  Tick-borne encephalitis carries a high risk of incomplete recovery in children. , 2013, The Journal of pediatrics.

[2]  H. Tsukahara,et al.  Prognostic value of brain injury biomarkers in acute encephalitis/encephalopathy , 2013, Pediatrics international : official journal of the Japan Pediatric Society.

[3]  James C. Cronk,et al.  IL-4 in the Brain: A Cytokine To Remember , 2012, The Journal of Immunology.

[4]  P. Gasque,et al.  Encephalitis due to emerging viruses: CNS innate immunity and potential therapeutic targets. , 2012, The Journal of infection.

[5]  L. Lindquist,et al.  One-year Follow-up of Tick-borne Central Nervous System Infections in Childhood , 2012, The Pediatric infectious disease journal.

[6]  T. Covassin,et al.  The Role of Age and Sex in Symptoms, Neurocognitive Performance, and Postural Stability in Athletes After Concussion , 2012, The American journal of sports medicine.

[7]  S. Ygberg,et al.  The developing immune system – from foetus to toddler , 2012, Acta paediatrica.

[8]  L. Lindquist,et al.  Pediatric tick-borne infections of the central nervous system in an endemic region of Sweden: a prospective evaluation of clinical manifestations , 2012, European Journal of Pediatrics.

[9]  J. Zajkowska,et al.  Evaluation of CXCL10, CXCL11, CXCL12 and CXCL13 chemokines in serum and cerebrospinal fluid in patients with tick borne encephalitis (TBE). , 2011, Advances in medical sciences.

[10]  I. Grgic,et al.  Concentration gradient of CXCL10 and CXCL11 between the cerebrospinal fluid and plasma in children with enteroviral aseptic meningitis. , 2011, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[11]  K. Shirabe,et al.  Serum and cerebrospinal fluid cytokine profile of patients with 2009 pandemic H1N1 influenza virus-associated encephalopathy. , 2011, Cytokine.

[12]  J. Süss Tick-borne encephalitis 2010: epidemiology, risk areas, and virus strains in Europe and Asia-an overview. , 2011, Ticks and tick-borne diseases.

[13]  L. Lindquist,et al.  Tick-borne encephalitis is associated with low levels of interleukin-10 in cerebrospinal fluid , 2011, Infection ecology & epidemiology.

[14]  H. Budka,et al.  Inflammatory response in human tick-borne encephalitis: analysis of postmortem brain tissue , 2006, Journal of NeuroVirology.

[15]  D. Růžek,et al.  Tick-borne encephalitis: pathogenesis and clinical implications. , 2010, Travel medicine and infectious disease.

[16]  F. Hufert,et al.  Tick-borne encephalitis virus and the immune response of the mammalian host. , 2010, Travel medicine and infectious disease.

[17]  M. Kubota,et al.  Serum and cerebrospinal fluid levels of cytokines in acute encephalopathy associated with human herpesvirus-6 infection , 2009, Brain and Development.

[18]  Y. Itoyama,et al.  Prognostic value of cerebrospinal fluid cytokine changes in herpes simplex virus encephalitis. , 2009, Cytokine.

[19]  L. Lindquist,et al.  Tick-borne encephalitis in Sweden in relation to aseptic meningo-encephalitis of other etiology: a prospective study of clinical course and outcome , 1997, Journal of Neurology.

[20]  Orsolya Farkas,et al.  Update on protein biomarkers in traumatic brain injury with emphasis on clinical use in adults and pediatrics , 2009, Acta Neurochirurgica.

[21]  M. Eriksson,et al.  Childhood encephalitis in Sweden: etiology, clinical presentation and outcome. , 2008, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[22]  H. Gnehm,et al.  Tick-Borne Encephalitis in Swiss Children 2000–2004: Five-Year Nationwide Surveillance of Epidemiologic Characteristics and Clinical Course , 2008, The Pediatric infectious disease journal.

[23]  O. Vapalahti,et al.  Tick-borne encephalitis , 2008, The Lancet.

[24]  A. Petzold CSF biomarkers for improved prognostic accuracy in acute CNS disease , 2007, Neurological research.

[25]  A. Vince,et al.  Chemokines CXCL10 and CXCL11 in the cerebrospinal fluid of patients with tick‐borne encephalitis , 2007, Acta neurologica Scandinavica.

[26]  N. M. Dung,et al.  Proinflammatory cytokines and chemokines in humans with Japanese encephalitis. , 2004, The Journal of infectious diseases.

[27]  M. Hosoya,et al.  Cytokine and cellular inflammatory sequence in enteroviral meningitis. , 2003, Pediatrics.

[28]  M. Haglund,et al.  Tick-borne encephalitis--pathogenesis, clinical course and long-term follow-up. , 2003, Vaccine.

[29]  L. Hagberg,et al.  Difference in pathogenesis between herpes simplex virus type 1 encephalitis and tick-borne encephalitis demonstrated by means of cerebrospinal fluid markers of glial and neuronal destruction , 2000, Journal of Neurology.

[30]  L. Lindquist,et al.  Tick-bone encephalitis in Sweden in relation to aseptic meningo-encephalitis of other etiology: a prospective study of clinical course and outcome. , 1997, Journal of neurology.